Influence of Ni (II) oxime complex coupled with the combination of diverse sized ZnO nanoparticles on Photovoltaic Performance

The one side selective synthesis of quinoline carboxylic acid oxime complex was carried out successfully. The as-prepared quinoline carboxylic acid oxime complex was complexed with nickel (II) salts to form nickel (II) oxime complex. These complexes were further adsorbed onto ZnO films containing ZnO nanoparticles of various sizes. ZnO films containing a diverse proportion of ZnO nanoparticles were investigated to enhance the photovoltaic efficiency of the dye-sensitized solar cell. The as-synthesized complex was characterized by scanning electron microscopy (SEM), Ultra violet visible spectroscopy (UV-vis), Fourier Transform Infrared Spectroscopy (FT-IR) spectroscopy, 1Hydrogen Nuclear magnetic resonance spectroscopy (1HNMR), Liquid chromatography coupled with mass spectrometry (LC-MR), Brunauer–Emmett–Teller (BET), and Attenuated total reflection Infra-red spectroscopy (ATR-IR). The combination of large and small ZnO nanoparticles has significantly improves the photovoltaic efficiency. The optimum mixing ratio for the best performance (0.127%) of a dye-sensitized solar cell is achieved by mixing the small: large ZnO particles in a ratio 60:40. The increased efficiency is due to the harvesting of light caused by scattering effect from larger sized ZnO particles. The ZnO layer consisting of smaller particles which are very next to the ZnO bigger particles makes a good electronic contact between film electrode and the Indium-doped tin oxide glass substrate resulting in the increases in the dye molecules adsorption. The over-layered, large-sized ZnO particles enhance the light-harvesting by light scattering effect. Compared to the other mixtures of ZnO films, there is a decrease in the photovoltaic performance of the solar cell when ZnO particles (small and large in a ratio 1:1) were adsorbed onto the Ni (II) oxime complex, which are caused due to the decrease in the surface area and dye aggregation.

Improvement of mechanical-antibacterial performances of AR/PMMA with TiO2 and HPQM treated by N-2(aminoethyl)-3-aminopropyl trimethoxysilane

The mechanical and antibacterial properties of acrylic rubber/poly(methyl methacrylate) (AR/PMMA) blend at 10 to 50 wt% of AR content with non-treated and treated titanium dioxide (TiO2) and 2-Hydroxypropyl-3-piperazinyl-quinoline carboxylic acid methacrylate (HPQM) by N-2(aminoethyl)-3-aminopropyl trimethoxysilane were studied. The antibacterial property against Escherichia coli was evaluated. The results found that the mechanical properties of ARt-TiO2/PMMA and ARt-HPQM/PMMA blend were higher than that of the ARTiO2/PMMA and ARHPQM/PMMA blend. For antibacterial property, the ARHPQM/PMMA and ARt-HPQM/PMMA blend could act as the antibacterial material, while the ARTiO2/PMMA blend did not show. However, the ARt-TiO2/PMMA blend could inhibit bacterial cell growth with 10 to 30 wt% of AR content. The recommended compositions of ARt-TiO2/PMMA blend, which improved both mechanical and antibacterial properties, were 10 to 30 wt% of AR and were 10 to 50 wt% of AR for ARt-HPQM/PMMA. Moreover, the UV radiation increased the antibacterial properties by the destruction of the interaction in treated TiO2 and HPQM and improved the antibacterial performance of ARt-TiO2/PMMA and ARt-HPQM/PMMA blend.

New Hydrazide-hydrazone Derivatives of Quinoline 3-Carboxylic Acid Hydrazide: Synthesis, Theoretical Modeling and Antibacterial Evaluation

A series of biologically active 3-quinoline carboxylic acid hydrazide-hydrazones has been synthesized from 3-quinoline carboxylic acid hydrazide and a variety of aldehydes, with moderate to good yields. The chemical structures of the new products were confirmed by elemental analysis, IR, and 1H NMR, 13C NMR spectral data. The structural and frontier molecular orbital (FMO) properties and the density functional theory (DFT) calculations were conducted for the new compounds. The new hydrazide-hydrazones exhibited low to moderate antibacterial activity against Staphylococcus aureus and Esherichia coli in comparison with gentamycin. Among the tested compounds, compounds 9 and 13 were found to be the most active. Phthalimide derivative 2 of 3-quioline carboxylic acid hydrazide showed remarkable antibacterial activity.

QSAR and molecular docking studies on 4-quinoline carboxylic acid derivatives as inhibition of vesicular stomatitis virus replication

The current study describes the development of in silico models based on quantitative structure-activity relationship (QSAR) analysis has been performed on 4-quinoline carboxylic acid derivatives as inhibition capacity of vesicular stomatitis virus replication in Madin Darby canine kidney epithelial cells. A highly descriptive and predictive QSAR model was obtained through the calculation of alignment-independent descriptors using MOE 2009.10 software. For a training set of 20 compounds, the partial least squares analyses result in a model which displays a squared correlation coefficient (r2) of 0.913. Validation of this model was performed using leave-one-out (q2) of 0.842. This model gives (r2pre) of 0.889 for a test set of five compounds. Docking studies were performed for 25 compounds to investigate the mode of interaction between 4-quinoline carboxylic acid derivatives and the active site of the human dihydroorotate dehydrogenase.

Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection

Mycoplasma genitalium is an important pathogen that is transmitted through sexual contact. For patients diagnosed with M. genitalium infection, the current guidelines recommend 1 g of azithromycin as the first-line treatment. Moxifloxacin is used as a second-line drug due to its remarkable efficacy; however, increased use of moxifloxacin to treat M. genitalium infections has caused the emergence of cases of moxifloxacin treatment failure. This meta-analysis aims to estimate the treatment efficacy of moxifloxacin for M. genitalium infection. Electronic databases were searched for articles published from 1983 to the end of May 2016 using the following search terms: ( Mycoplasma genitalium) AND (moxifloxacin OR 1-cyclopropyl–7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinoline carboxylic acid OR Proflox OR moxifloxacin hydrochloride OR Octegra OR Avelox OR Avalox OR Izilox OR Actira OR [treatment efficacy]). All included studies were published in English; all participants were diagnosed with M. genitalium infection, and microbial cure times were measured within 12 months after treatment. Treatment efficacy was measured as microbial cure at the final follow-up after treatment. In total, 17 studies including 252 participants met the inclusion criteria. The majority of these studies were observational. The random-effects pooled microbial cure rate was 96% (95% confidence interval [CI], 90%–99%; I2 = 28.59%, P = 0.13). For studies with sample collection deadlines prior to 2010, the pooled microbial cure rate was 100% (95% CI, 99%–100%; I2 = 0.00%, P = 1.00). For studies with sample collection deadlines of 2010 and later, the pooled microbial cure rate was 89% (95% CI, 82%–94%; I2 = 0.00%, P = 0.59). The elimination rate of moxifloxacin for M. genitalium infection has decreased from 100% to 89% since 2010. This decline merits considerable attention. We suggest close follow-up to investigate the efficacy of moxifloxacin for treating M. genitalium infections. Additionally, sentinel points should be established to detect mutations in the gyrA/B and parC/E genes, which are associated with moxifloxacin resistance.